| The emergence of Exercise Addiction, Body Dysmorphic Disorder, and other image-related psychopathological correlates in fitness settings: A cross sectional study O Corazza, P Simonato, Z Demetrovics, R Mooney, K van de Ven, ... PloS one 14 (4), e0213060, 2019 | 121 | 2019 |
| Social suppliers: Exploring the cultural contours of the performance and image enhancing drug (PIED) market among bodybuilders in the Netherlands and Belgium K van de Ven, KJD Mulrooney International Journal of Drug Policy 40, 6-15, 2017 | 104 | 2017 |
| The symbiotic evolution of anti-doping and supply chains of doping substances: how criminal networks may benefit from anti-doping policy B Fincoeur, K Van de Ven, KJD Mulrooney Trends in Organized crime 18, 229-250, 2015 | 96 | 2015 |
| Exploring the relationship between online buyers and sellers of image and performance enhancing drugs (IPEDs): Quality issues, trust and self-regulation K van de Ven, R Koenraadt International Journal of Drug Policy 50, 48-55, 2017 | 78 | 2017 |
| The Internet and lifestyle drugs: an analysis of demographic characteristics, methods, and motives of online purchasers of illicit lifestyle drugs in the Netherlands R Koenraadt, K van de Ven Drugs: Education, Prevention and Policy 25 (4), 345-355, 2018 | 59 | 2018 |
| Health risk and health seeking behaviours among people who inject performance and image enhancing drugs who access needle syringe programs in Australia K van de Ven, L Maher, H Wand, S Memedovic, E Jackson, J Iversen Drug and Alcohol Review, 2018 | 59 | 2018 |
| The impact of rurality on opioid-related harms: a systematic review of qualitative research N Thomas, K van de Ven, KJD Mulrooney International Journal of Drug Policy 85, 102607, 2020 | 54 | 2020 |
| Steroid madness-has the dark side of anabolic-androgenic steroids (AAS) been over-stated? KJD Mulrooney, K van de Ven, J McVeigh, R Collins Performance Enhancement & Health 6 (3-4), 98-102, 2019 | 54 | 2019 |
| An introduction to human enhancement drugs K van de Ven, KJD Mulrooney Human Enhancement Drugs, 2020 | 46 | 2020 |
| ‘Blurred lines’: Anti-doping, national policies, and the performance and image enhancing drug (PIED) market in Belgium and The Netherlands K van de Ven Performance Enhancement & Health 4 (3-4), 94-102, 2016 | 43 | 2016 |
| The burgeoning recognition and accommodation of the social supply of drugs in international criminal justice systems: An eleven-nation comparative overview R Coomber, L Moyle, V Belackova, T Decorte, P Hakkarainen, ... International Journal of Drug Policy 58, 93-103, 2018 | 38 | 2018 |
| Testing the boundaries: Self-medicated testosterone replacement and why it is practised M Underwood, K van de Ven, M Dunn International Journal of Drug Policy 95, 103087, 2021 | 37 | 2021 |
| Performance and image enhancing drug interventions aimed at increasing knowledge among healthcare professionals (HCP): reflections on the implementation of the Dopinglinkki e … AM Atkinson, K Van De Ven, M Cunningham, T de Zeeuw, E Hibbert, ... International Journal of Drug Policy 95, 103141, 2021 | 32 | 2021 |
| Performance and image enhancing drug (PIED) producers and suppliers: a retrospective content analysis of PIED-provider cases in Australia from 2010-2016 K van de Ven, M Dunn, K Mulrooney Trends in Organized Crime 23, 143-153, 2020 | 31 | 2020 |
| Alcohol and other drug (AOD) staffing and their workplace: examining the relationship between clinician and organisational workforce characteristics and treatment outcomes in … K van de Ven, A Ritter, A Roche Drugs: Education, Prevention and Policy 27 (1), 1-14, 2020 | 29 | 2020 |
| The modes of administration of anabolic-androgenic steroid (AAS) users: are non-injecting people who use steroids overlooked? K van de Ven, R Zahnow, J McVeigh, A Winstock Drugs: Education, Prevention and Policy 27 (2), 131-135, 2020 | 28 | 2020 |
| Overview of “home” cultivation policies and the case for community-based cannabis supply V Belackova, M Roubalova, K van de Ven International Journal of Drug Policy 71, 36-46, 2019 | 26 | 2019 |
| The pharmaceuticalisation of ‘healthy’ageing: Testosterone enhancement for longevity M Dunn, KJD Mulrooney, C Forlini, K van de Ven, M Underwood International Journal of Drug Policy 95, 103159, 2021 | 25 | 2021 |
| Perceptions of purchasing and payment mechanisms in alcohol and other drug treatment services in Australia: A qualitative study involving alcohol and other drug service … K van de Ven, A Ritter, L Berends, J Chalmers, K Lancaster Drug and Alcohol Review 39 (2), 189-197, 2020 | 22 | 2020 |
| The impact of the COVID-19 pandemic on male strength athletes who use non-prescribed anabolic-androgenic steroids BN Zoob Carter, ID Boardley, K Van de Ven Frontiers in Psychiatry 12, 636706, 2021 | 20 | 2021 |
Kyle MulrooneySenior Lecturer in Criminology, University of New EnglandVerified email at une.edu.au
